News
A new article in JOJ Ophthalmology confirms Tixel i® provides sustained, strong clinical outcomes for patients with ...
The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback